The role of YY1 in promoting cancer immune evasion

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• The immune system is crucial for preventing cancer, but cancer cells can evade immune surveillance.
• Dysregulation of key regulators contributes to immune evasion, necessitating research into therapeutic targets.
• Yin Yang 1 (YY1) is a transcription factor implicated in both cancer development and immune evasion.

Purpose of the Study:

• To review and categorize mechanisms of cancer immune evasion regulated by Yin Yang 1 (YY1).
• To elucidate how YY1 facilitates cancer cells' avoidance of immune recognition and attack.
• To discuss the complex regulatory network involving YY1 in cancer immune evasion.

Main Methods:

• Literature review and synthesis of existing studies on YY1 and cancer immune evasion.
• Categorization of YY1-regulated immune evasion into camouflage, coercion, and cytoprotection frameworks.
• Analysis of gene expression networks influenced by YY1 in various cancers.

Main Results:

• YY1 enables cancer cells to avoid immune recognition through mechanisms like 'camouflage'.
• YY1 attenuates the anti-tumor functions of immune effector cells via 'coercion'.
• YY1 protects cancer cells from immune cell-mediated cytotoxicity through 'cytoprotection' pathways.

Conclusions:

• YY1 is a key regulator of cancer immune evasion, employing diverse strategies to promote tumor survival.
• Targeting YY1-mediated pathways offers potential for developing novel anticancer immunotherapies.
• Further research is needed to fully understand the complex YY1 regulatory network in cancer.